NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,688,445 | -18.5% | 534,318 | -0.2% | 0.00% | – |
| Q2 2023 | $2,071,484 | +68.0% | 535,267 | +20.3% | 0.00% | – |
| Q1 2023 | $1,232,830 | +54.4% | 445,065 | +0.3% | 0.00% | – |
| Q4 2022 | $798,462 | -15.5% | 443,590 | -0.4% | 0.00% | – |
| Q3 2022 | $945,000 | -21.8% | 445,374 | -0.9% | 0.00% | – |
| Q2 2022 | $1,209,000 | +98.5% | 449,598 | +220.4% | 0.00% | – |
| Q1 2022 | $609,000 | -18.6% | 140,324 | -2.8% | 0.00% | – |
| Q4 2021 | $748,000 | +34.5% | 144,347 | +59.4% | 0.00% | – |
| Q3 2021 | $556,000 | – | 90,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 16,298,006 | $34,552,000 | 24.08% |
| Madrona Venture Group, LLC | 6,020,770 | $12,764,000 | 5.87% |
| AH Equity Partners LSV II, L.L.C. | 1,355,911 | $2,875,000 | 2.57% |
| Tikvah Management LLC | 1,488,895 | $3,156,000 | 1.46% |
| ArchPoint Investors | 1,449,551 | $3,073,000 | 1.26% |
| Ally Bridge Group (NY) LLC | 823,974 | $1,747,000 | 1.15% |
| Perceptive Advisors | 9,111,151 | $19,315,000 | 0.56% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $4,240,000 | 0.51% |
| BRIDGER MANAGEMENT, LLC | 413,700 | $877,000 | 0.27% |
| Decheng Capital Management III (Cayman), LLC | 300,000 | $636,000 | 0.23% |